We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 3.45% | 150.00 | 140.00 | 160.00 | 150.00 | 150.00 | 150.00 | 1,565 | 08:00:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -28.73M | -0.4177 | -3.59 | 103.18M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/5/2018 07:39 | Top of the leaderboard likely today | kirk 6 | |
09/5/2018 21:36 | US Food and Drug Administration (FDA) proposed that Faron proceed directly to BLA submission for Traumakine in the US upon successful completion of the European and Japanese Phase III trials. FDA Fast Track Designation was granted in January. Initiation of a collaboration with Syneos Health for Traumakine - a global biopharmaceutical solutions organization with end-to-end clinical development and commercialization capabilities. | shirley83 | |
09/5/2018 21:35 | .. Lots of programs on the go and this is still happening in Japan. Think of it as a duster for a 3 drill campaign... Yep the drop then people realise the next drill etc.. They have money and small float.. People will average down from now.. 300p coming | shirley83 | |
09/5/2018 21:33 | If that's what you think then good for you. I don't see any value above 50pps as it stands today. I keep going over what assets they have and I only see hopes and uncertainty. I don't invest in hopes and uncertainty, as 99? certain can end you up with 1% loss of your investment. I've said my piece for what it's worth. Good luck. | deltalo | |
09/5/2018 21:06 | - not over yet.. Japanese partner Maruishi continued to progress their pivotal Phase III ARDS trial in Japan and has received two IDMC recommendations to continue the trial as planned. Maruishi anticipates completion of recruitment of this 120-patient study in mid 2018. | shirley83 | |
09/5/2018 20:45 | The bounce has happened but like a bouncing ball the heigh's get lower with each bounce. There is no income to pay for any new trials let alone pay for the rest of the last one. The whole inflation in the share price was on the back of a positive outcome from this trial from the start. What I would like to know is where's the funding coming from and if there is any new trials, how much and how many years will it take. I know something and that's I'm not waiting and I'm not paying. This will fall to its real worth. | deltalo | |
09/5/2018 20:00 | If we get high volume then yes | shirley83 | |
09/5/2018 19:55 | 3 quid by close of play tommorow | mrworry | |
09/5/2018 17:40 | Agreed this could easily do 100% | kirk 6 | |
09/5/2018 17:36 | Ignore - posted on wrong chat | rk23 | |
09/5/2018 17:20 | Don't think many people have spotted it... Biggest riser tomorrow.. 200p+ | letmepass | |
09/5/2018 16:52 | Massive closing auction I could sell 25k shares 2p higher than the offer !! What a day tomorrow will bs | kirk 6 | |
09/5/2018 15:36 | NT to buy again | shirley83 | |
09/5/2018 15:16 | Fingers crossed for the 38 fib.....relentless buying pressure | jasonavfc19 | |
09/5/2018 15:12 | Tommorow will be an interesting day.. | shirley83 | |
09/5/2018 15:10 | 357 is 38 fib | shirley83 | |
09/5/2018 15:08 | Holy cow £1.40 being smashed now | kirk 6 | |
09/5/2018 14:50 | Here we go...breaking £1.30!!! Short term Target £2.50 | kirk 6 | |
09/5/2018 14:47 | Although NT to buy... Mmmm | shirley83 | |
09/5/2018 14:38 | Agree this is going sub 1p | shirley83 | |
09/5/2018 14:36 | with Polar selling i would stay well clear!!! | pjj71 | |
09/5/2018 14:23 | Boooooooom another winner buy anyway here and sellFor 100% gains | kirk 6 | |
09/5/2018 14:21 | Late reports look like the supply, seems to be churning through fine though. | superg1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions